The global cardiac marker testing market is expected to grow at a CAGR of 8.9% from USD 3.6 billion in 2020 to USD 5.5 billion by 2025, from USD 3.6 billion in 2020. Growing incidence of cardiovascular diseases, rapidly increasing geriatric population, and growing funding from public and private organisations for cardiac biomarker research are driving growth in the cardiac marker testing market.
COVID-19 Impact on the global market for cardiac marker testing
The Cardiac Biomarkers Market has also experienced a period of short-term negative growth, which may be linked to factors including a more than 50% decline in the number of patients with cardiovascular diseases and those diagnosed with myocardial infarction. All aspects of cardiology service provision, including outpatient clinics, investigations, surgeries, and cardiology community services like cardiac rehabilitation, saw considerable cutbacks.
Read More @ https://cmiinfopiece.blogspot.com/2021/12/the-global-cardiac-biomarker-market-is.html
Source Link:https://bit.ly/3yATzJO
